Asia-Pacific markets traded mostly higher Monday, as investors assessed China's manufacturing and industrial profit data.

Viehbacher, “Biogen”) announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as treatment for early AD (mild cognitive impairment due to ...

Listed companies will also be encouraged to do more stock buybacks and raise dividends to improve shareholder returns, the ...

In November, the Securities and Exchange Commission tentatively approved ... its main business had been currency trading. Once some key regulatory infrastructure is in place, it plans to open ...

China’s financial market regulator has pledged to prioritise market stability and confidence this year as the country braces for more uncertainty. In an article published in Communist Party ...

The China Securities Regulatory Commission said stability is top of its agenda in 2025 as it pledged to make every effort to induce and maintain the market’s stabilizing and positive momentum ...

A view of the headquarters of China Securities Regulatory Commission in Beijing. [CHINA DAILY] BEIJING -- The China Securities Regulatory Commission (CSRC) on Sunday released an action plan to ...

China rolled out a basket of measures to stabilize its stock markets, including plans to boost the amount pension can invest ...